Article

CIBA Vision voluntarily recalls lotrafilcon B lenses

Duluth, GA-CIBA Vision Corp. has launched a voluntary trade-level recall of select lots of O2Optix (lotrafilcon B) contact lenses, distributed primarily in the United States, and in other countries excluding Japan.

Duluth, GA-CIBA Vision Corp. has launched a voluntary trade-level recall of select lots of O2Optix (lotrafilcon B) contact lenses, distributed primarily in the United States, and in other countries excluding Japan.

According to a statement, the company "[took] this action because we have identified that some lenses in these lots did not meet our standards for ion permeability, a material characteristic which contributes to lens movement on the eye. Some lenses with reduced ion permeability may cause persistent discomfort until the lens is removed, which could lead to corneal irritation for some wearers."

The CIBA Vision U.S. consumer Web site, http://www.us.cibavision.com/, offers users an apology for the current unavailability of O2Optix product. "This situation is due to a number of different factors including manufacturing capacity issues and a recent limited voluntary, trade-level recall from eye-care professional, distributor, and retailer inventories," according to the company's Web site.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.